Work

Supplementary Figures S1-S5 from A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers

Year: 2023

Type: supplementary-materials

Abstract: Comparison of MYCN and MYC expression levels between MYCN amplified and non-MYCN amplified (non-MNA) neuroblastomas (S1); Prognostic significance of MYCN and MYC genes in non-MYCN amplified neuroblastoma (S2); Relationship between signature score and MYCN protein expression in neuroblastoma (S3); Comparison of signature score between normal and cancerous tissues (S4); Expression of MYCN and signature score in molecular subtypes of HG-SOC (S5).

DOI: 10.1158/0008-5472.22411125

Authors: MoonSun Jung, Amanda J. Russell, Bing Liu, Joshy George, Pei Yan Liu, Tao Liu, Anna DeFazio, David D.L. Bowtell, André Oberthuer, Wendy B. London, Jamie I. Fletcher, Michelle Haber, Murray D. Norris, Michelle J. Henderson

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361875870

Cites:

Cited by:

Related to: 10